Israel Englander Oncolytics Biotech Inc Transaction History

Millennium Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.89 - $1.36 $77,389 - $118,258	-86,955 Reduced 68.02%	40,887 $43,000
Q4 2023 Feb 14, 2024	BUY	$1.22 - $2.09 $155,967 - $267,189	127,842 New	127,842 $172,000
Q4 2022 Feb 14, 2023	BUY	$1.17 - $2.12 $30,056 - $54,460	25,689 New	25,689 $42,000
Q4 2018 Feb 14, 2019	SELL	$1.72 - $4.12 $80,088 - $191,839	-46,563 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$3.83 - $5.92 $1.7 Million - $2.62 Million	-442,968 Reduced 90.49%	46,563 $180,000
Q2 2018 Aug 14, 2018	BUY	$4.56 - $7.83 $2.23 Million - $3.83 Million	489,531 New	489,531 $2.69 Million

1.18M

Ticker ONCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,867,400
Market Cap $49.2M
Description
Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.